Optometry Times Staff Reports

Shamir joined the Alpine in May 2021 in partnership with Alpine F1 Team to enhance the visual quality and safety of its race team members.

The actress and singer-songwriter will serves as the brand ambassador for OptiLight, a new dry eye disease treatment.

The removal of preservatives may be beneficial for the ocular health of glaucoma patients

The optical technology company announced two updates to their product line.

Black EyeCare Perspective is connecting communities with Black eye care professionals, optometrists and ophthalmologists

Faricimab is now the first and only FDA-approved drug to target two distinct pathways known to cause retinal disease that may lead to vision loss.

Ahead of World Neglected Tropical Diseases (NTD) Day on Jan. 30, Alemayehu Sisay, MD, MPH, country director for Orbis Ethiopia, discusses efforts and progress the organization has made in treating patients with NTDs and how to get involved in recognizing World NTD Day.

Weigh in on our poll!

Research also highlights the top factors that lead to care, which can be used to improve parents' uptake of sight-saving surgery for their children.

The annual national conference in February will offer 3 intensive days of business management curricula, COPE-approved clinical education, staff training and high-profile guest speakers.

Positive one-year results of Genentech’s phase III trials analyzing faricimab for treatment of wet AMD and DME were released today.

Alcon has launched the latest addition to its European dry eye products portfolio: Systane Complete Preservative-Free Lubricant Eye Drop, available in an easy-to-use, multi-dose bottle, the company announced last week.

Transitions Optical's Diversity Advisory Board members share how eyecare professionals can incorporate diversity, equity and inclusion in their lives and careers.

AACO will once again be participating in a co-located meeting at SECO 2022 in New Orleans, March 9-13. AACO will be presenting 4 hours of FREE CE as well as a CE Dinner open to all Optometrists, free for AACO members.

ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.

The 25th annual event was originally scheduled for January 16-19.

Exciting news from OYE Technology!

Landmark initiative emphasizes shared responsibilities for patients' health care

Advanstar Communications' "Cardiometabolic Disorders and Weight: Action for Outcomes" initiative brings together comprehensive tools and information from our Web portal ModernMedicine.com, our 15 healthcare brands, and two of our pharmaceutical science publications.

For the first time, 17 of Advanstar Communications' Life Sciences publications and their Web portal, ModernMedicine.com, are collaborating in a coordinated, interdisciplinary initiative to address a major public health issue: cardiometabolic disorders and weight.

For the first time, 17 of Advanstar Communications' Life Sciences publications and their Web portal, ModernMedicine.com, are collaborating in a coordinated, interdisciplinary initiative to address a major public health issue: cardiometabolic disorders and weight.

Viva International has released eight new prescription-ready sunglass styles for men and women in its Harley-Davidson Eyewear collection.

The latest special edition frame from Marc Jacobs is designed to have an edgy appeal, borrowing from the glam-rock era sprinkled with a touch of punk.

With sun safety a growing concern and the sun season in full swing, Vision-Ease Lens (VEL) and the Skin Cancer Foundation (SCF) are working together to educate consumers about the importance of sun protection for the eyes.

S

Results of a survey conducted by Transitions Optical reveal that women are significantly more likely than men to experience various eye conditions and vision problems and more likely to identify certain health and environmental factors as negatively affecting vision.

Teens with blindness or low vision face a greater number of hurdles as they transition to adult life. Making a successful transition can require not only academic training but also vocational, social, and personal development.

Bausch & Lomb (B&L) launched the Center for Patient Insights to increase access to unbiased industry information, trends, market research and insights for eye-care professionals (ECPs) across the country.